Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses
Viruses · 2023
DOI: 10.3390/v15091936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Samuel Santos Pereira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Vaccine Development, Institute of Biomedical Sciences, Department of Microbiology, University of São Paulo, São Paulo 05508-000, Brazil. Hauptthemen laut MEDLINE: Dengue Virus, Dengue, Antibodies, Viral, Antigens, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development, São Paulo Research Foundation.
Abstract (Originalsprache)
Dengue is an infectious disease of global health concern that continues to require surveillance. Serological testing has been used to investigate dengue-infected patients, but specificity is affected by the co-circulation of ZIKA virus (ZIKV), which shares extensive antigen similarities. The goal of this study was the development of a specific dengue virus (DENV) IgG ELISA based on a multi-epitope NS1-based antigen for antibody detection. The multi-epitope protein (T-ΔNS1), derived from a fragment of the NS1-protein of the four DENV serotypes, was expressed in Escherichia coli and purified via affinity chromatography. The antigenicity and specificity were evaluated with sera of mice infected with DENV-1–4 or ZIKV or after immunization with the recombinant ΔNS1 proteins. The performance of the T-ΔNS1-based IgG ELISA was also determined with human serum samples. The results demonstrate that the DENV T-ΔNS1 was specifically recognized by the serum IgG of dengue-infected mice or humans but showed no or reduced reactivity with ZIKV-infected subjects. Based on the available set of clinical samples, the ELISA based on the DENV T-ΔNS1 achieved 77.42% sensitivity and 88.57% specificity. The results indicate that the T-ΔNS1 antigen is a promising candidate for the development of specific serological analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Vaccine Development, Institute of Biomedical Sciences, Department of Microbiology, University of São Paulo, São Paulo 05508-000, Brazil.
- Institut Pasteur de São Paulo, São Paulo 05508-020, Brazil.
- General Pathology, Universidade de Pernambuco, Recife 50100-130, Brazil.
ORCID-Profile: Samuel Santos Pereira, Maria Fernanda de Castro-Amarante, Mariângela de Oliveira Silva, Rúbens Prince Dos Santos Alves, Luís Carlos de Souza Ferreira
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- National Council for Scientific and Technological Development
- São Paulo Research Foundation
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Zitieren
APA
Pereira, S. S., Andreata-Santos, R., de Castro-Amarante, M. F., Venceslau-Carvalho, A. A., Sales, N. S., Silva, M. O., Alves, R. P. D. S., Jungmann, P., & Ferreira, L. C. S. (2023). Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses. Viruses. https://doi.org/10.3390/v15091936
Vancouver
Pereira SS, Andreata-Santos R, de Castro-Amarante MF, Venceslau-Carvalho AA, Sales NS, Silva MO, et al. Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses. Viruses. 2023. doi:10.3390/v15091936
BibTeX
@article{Pereira2023,
author = {Pereira, Samuel Santos and Andreata-Santos, Robert and de Castro-Amarante, Maria Fernanda and Venceslau-Carvalho, Aléxia Adrianne and Sales, Natiely Silva and Silva, Mariângela de Oliveira and Alves, Rúbens Prince Dos Santos and Jungmann, Patrícia and Ferreira, Luís Carlos de Souza},
title = {Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15091936}
}
EUVIMED